Evidence map›Paper›PMID 26220109›Full record

ArticleTechniques in coloproctology2015

Transanal total mesorectal excision assisted by single-port laparoscopic surgery for low rectal cancer.

W-H Chen, L Kang, S-L Luo, X-W Zhang, Y Huang, Z-H Liu, J-P Wang

2 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in Techniques in coloproctology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02236884 phase1 / phase2completednot on this map

A Pilot Study of the Feasibility and Safety of No-scar Transanal Total Mesorectal Excision for Rectal Cancer Without Conventional Laparoscopic Assistance

TypeinterventionalSponsorSun Yat-sen UniversityRan2014 to 2016Enrolled20ConditionsRectal Cancer, SurgeryArmsno-scar transanal total mesorectal excision(TME)
NCT02966483 narecruitingnot on this mapstarted 2016, after this paper: background citation

Transanal Versus Laparoscopic Total Mesorectal Excision for Mid and Low Rectal Cancer (TaLaR): a Multicentre Randomised Clinical Trial

TypeinterventionalSponsorSun Yat-sen UniversityRan2016 to 2026Enrolled1,114ConditionsRectal Neoplasms Malignant, SurgeryArmsTaTME, LpTME
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Evaluation of the learning curve of transanal total mesorectal excision: single-centre experience.Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Transanal Total Mesorectal Excision With Single-Incision Laparoscopy for Rectal Cancer.JSLS : Journal of the Society of Laparoendoscopic Surgeons
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

W-H ChenDepartment of Colorectal Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, 26 Yuancun Erheng Rd, Guangzhou, 510655, People's Republic of China.
L Kang
S-L Luo
X-W Zhang
Y Huang
Z-H Liu
J-P Wang
Sixth Affiliated Hospital of Sun Yat-sen University · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWe have combined the minimally invasive single-port laparoscopic surgery and the transanal total mesorectal excision (TaTME) for rectal cancer with the goal to standardize the approach and improve the quality of rectal cancer resection.

methodsBy using two single-port platforms, selected patients were first operated by TaTME, and then a single-port laparoscopic surgery was introduced to assist and complete the abdominal portion. Short-term outcomes including perioperative outcome and pathologic results of these patients were evaluated.

resultsBetween July 2014 and March 2015, six patients with low rectal cancer (five males and one female) at a median age of 68 years were successfully operated in a median time of 360 min (range 310-420). The median estimated blood loss was 150 ml (range 50-800). In one patient, the spleen was removed because of a lesion identified preoperatively. Their postoperative recovery was uneventful except one acute myocardial infarction on postoperative day 3. Pathologic specimens showed negative margins and a complete excision of the mesorectum in all cases. The median number of harvested lymph nodes was 11.5 (range 4-12). At a median follow-up of 4 months (range 3-9), after ileostomy closure, none of the patients suffered from fecal incontinence.

conclusionTaTME assisted by abdominal single-port may be safely achieved in selected rectal cancer patients.

Indexed as

AbdomenAgedAnal CanalBlood Loss, SurgicalFemaleHumansIleostomyLaparoscopyLymph Node ExcisionMaleMedical IllustrationMiddle AgedOperative TimePostoperative ComplicationsRectal NeoplasmsRectum

Identifiers

PMID26220109
OpenAlexW1014497993

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.